Impact of pretreatment hemoglobin levels on tumor response, microvessel count and Ki67 expression in breast cancer patients undergoing primary chemotherapy.

被引：0
|
作者：
Bottini, A
Berruti, A
Brizzi, MP
Allevi, G
Bersiga, A
Generali, D
Aguggini, S
Bolsi, G
Bonardi, S
Alquati, P
Dogliotti, L
机构：
[1] Azienda Osped, Ist Ospitalieri, Cremona, Italy
[2] Azienda Osped San Luigi, Orbassano, Italy
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2002年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
223
引用
收藏
页码：S65 / S65
页数：1
相关论文
共 50 条
  • [41] Clinical significance of pretherapeutic Ki67 as a predictive parameter for response to neoadjuvant chemotherapy in breast cancer; is it equally useful across tumor subtypes?
    Sueta, Aiko
    Yamamoto, Yutaka
    Hayashi, Mitsuhiro
    Yamamoto, Satoko
    Inao, Toko
    Ibusuki, Mutsuko
    Murakami, Keiichi
    Iwase, Hirotaka
    SURGERY, 2014, 155 (05) : 927 - 935
  • [42] The role of Ki67 in involved lymph nodes as a predictive biomarker for response to neoadjuvant chemotherapy in patients with early breast cancer.
    Kolberg-Liedtke, Cornelia
    Hussein, Shady
    Bankfalvi, Agnes
    Steinborn, Julia
    Ting, Saskia
    Bittner, Ann-Kathrin
    Hoffmann, Oliver
    Pott, Birgit
    Hannig, Carla Verena
    Wetzig, Sarah
    Kolberg, Hans-Christian
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [43] Ki67 expression in breast cancer Correlation with prognostic markers and clinicopathological parameters in Saudi patients
    Elkablawy, Mohamed A.
    Albasri, Abdulkader M.
    Mohammed, Rabab A.
    Hussainy, Akbar S.
    Nouh, Magdy M.
    Alhujaily, Ahmed S.
    SAUDI MEDICAL JOURNAL, 2016, 37 (02) : 137 - 141
  • [44] Ki67 Expression and Docetaxel Efficacy in Patients With Estrogen Receptor-Positive Breast Cancer
    Penault-Llorca, Frederique
    Andre, Fabrice
    Sagan, Christine
    Lacroix-Triki, Magali
    Denoux, Yves
    Verriele, Veronique
    Jacquemier, Jocelyne
    Baranzelli, Marie Christine
    Bibeau, Frederic
    Antoine, Martine
    Lagarde, Nicole
    Martin, Anne-Laure
    Asselain, Bernard
    Roche, Henri
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (17) : 2809 - 2815
  • [45] Studies of the potential utility of Ki67 as a predictive molecular marker of clinical response in primary breast cancer
    Assersohn, L
    Salter, J
    Powles, TJ
    A'hern, R
    Makris, A
    Gregory, RK
    Chang, J
    Dowsett, M
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 (02) : 113 - 123
  • [46] Studies of the Potential Utility of Ki67 as a Predictive Molecular Marker of Clinical Response in Primary Breast Cancer
    L. Assersohn
    J. Salter
    T.J. Powles
    R. A'hern
    A. Makris
    R.K. Gregory
    J. Chang
    M. Dowsett
    Breast Cancer Research and Treatment, 2003, 82 : 113 - 123
  • [47] Association of ki67 and tumor marker p53 in locally advanced breast cancer patients and evaluation of response to neoadjuvant chemotherapy: a survey in South Iran
    Firouzabadi, Dena
    Rezvani, Alireza
    Dehghanian, Amirreza
    Mahmoudi, Laleh
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 6489 - 6497
  • [48] Association of Ki-67 expression in CTCs with disease relapse in patients with early breast cancer (BC) and affect by the administration of adjuvant chemotherapy.
    Mavroudis, Dimitrios
    Agelaki, Sofia
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [49] Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy
    Tan, Qi-Xing
    Qin, Qing-Hong
    Yang, Wei-Ping
    Mo, Qin-Guo
    Wei, Chang-Yuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (10): : 6862 - 6870
  • [50] PgR levels and Ki67 expression of Lobular Carcinomas of the Breast might indicate OncotypeDX testing to evaluate Chemotherapy benefit
    Markopoulos, Christos
    Sariyanni, Mahi
    Karamargiou, Asimina
    Antonopoulou, Zoi
    Tsoulos, Nikolaos
    CANCER RESEARCH, 2023, 83 (05)
12345